ECONAZOLE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 8 adverse event reports in the FDA FAERS database where ECONAZOLE was used for Psoriasis.
Most Reported Side Effects for ECONAZOLE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 62 | 13.8% | 0 | 5 |
| Rash maculo-papular | 44 | 9.8% | 0 | 43 |
| Acute generalised exanthematous pustulosis | 37 | 8.2% | 12 | 28 |
| Pruritus | 33 | 7.3% | 0 | 24 |
| Drug reaction with eosinophilia and systemic symptoms | 24 | 5.3% | 0 | 24 |
| Eosinophilia | 24 | 5.3% | 0 | 17 |
| Rash | 22 | 4.9% | 0 | 10 |
| Acute motor-sensory axonal neuropathy | 19 | 4.2% | 0 | 0 |
| Pyrexia | 18 | 4.0% | 0 | 17 |
| Condition aggravated | 17 | 3.8% | 0 | 2 |
| Product use in unapproved indication | 17 | 3.8% | 0 | 1 |
| Purpura | 17 | 3.8% | 0 | 8 |
| Renal failure | 17 | 3.8% | 0 | 3 |
| Erythema | 16 | 3.6% | 0 | 5 |
| Fall | 16 | 3.6% | 0 | 15 |
Other Indications for ECONAZOLE
Product used for unknown indication (130)
Fungal infection (95)
Fungal skin infection (22)
Intertrigo (21)
Rash (20)
Tinea pedis (16)
Trichophytosis (8)
Vulvovaginal candidiasis (8)
Vulvovaginal mycotic infection (7)
Candida infection (6)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)